Free Trial

bioAffinity Technologies (BIAF) Stock Price, News & Analysis

-0.08 (-3.15%)
(As of 05/29/2024 ET)
Today's Range
50-Day Range
52-Week Range
82,831 shs
Average Volume
165,829 shs
Market Capitalization
$28.68 million
P/E Ratio
Dividend Yield
Price Target
BIAF stock logo

About bioAffinity Technologies Stock (NASDAQ:BIAF)

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level. The company was incorporated in 2014 and is based in San Antonio, Texas.

BIAF Stock Price History

BIAF Stock News Headlines

bioAffinity Technologies News Update
bioAffinity Technologies News Update
bioAffinity Technologies News Update
bioAffinity Technologies In the News
See More Headlines
Receive BIAF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for bioAffinity Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Commercial physical research
Current Symbol
Year Founded


Net Income
Net Margins
Pretax Margin


Sales & Book Value

Annual Sales
$2.53 million
Book Value
$0.45 per share


Free Float
Market Cap
$28.57 million
Not Optionable
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Mr. Steven Girgenti (Age 78)
    Founder & Executive Chairman of the Board
    Comp: $113.75k
  • Ms. Maria Zannes J.D. (Age 68)
    Founder, President, CEO & Director
    Comp: $299.17k
  • Ms. Julie Anne Overton
    Director of Communications
  • Mr. Dallas J. Coleman
    National Director of Sales
  • Dr. William Bauta Ph.D.
    Senior Vice President of Therapeutics

BIAF Stock Analysis - Frequently Asked Questions

How have BIAF shares performed in 2024?

bioAffinity Technologies' stock was trading at $1.4705 at the beginning of the year. Since then, BIAF stock has increased by 67.3% and is now trading at $2.46.
View the best growth stocks for 2024 here

Are investors shorting bioAffinity Technologies?

bioAffinity Technologies saw a increase in short interest in May. As of May 15th, there was short interest totaling 423,000 shares, an increase of 7.1% from the April 30th total of 395,000 shares. Based on an average trading volume of 254,600 shares, the short-interest ratio is presently 1.7 days. Approximately 7.1% of the company's shares are short sold.
View bioAffinity Technologies' Short Interest

When is bioAffinity Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 12th 2024.
View our BIAF earnings forecast

How were bioAffinity Technologies' earnings last quarter?

bioAffinity Technologies, Inc. (NASDAQ:BIAF) announced its quarterly earnings results on Monday, April, 1st. The company reported ($0.26) earnings per share for the quarter. The company had revenue of $2.21 million for the quarter. bioAffinity Technologies had a negative trailing twelve-month return on equity of 134.34% and a negative net margin of 171.43%.

When did bioAffinity Technologies IPO?

bioAffinity Technologies (BIAF) raised $8 million in an initial public offering (IPO) on Thursday, September 1st 2022. The company issued 1,300,000 shares at $6.00-$6.25 per share. WallachBeth Capital served as the underwriter for the IPO and Craft Capital Management was co-manager.

How do I buy shares of bioAffinity Technologies?

Shares of BIAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BIAF) was last updated on 5/29/2024 by Staff

From Our Partners